TCM Limited Board Meeting Scheduled to Discuss Q1 Financials and FY25-26 Reports
TCM Limited, formerly known as Travancore Chemical & Mfg. Co. Ltd., has scheduled a meeting of its Board of Directors to review the company's performance for the quarter ended June 30, 2026. The Board Meeting is set to take place on Thursday, August 13, 2026, at 10:30 A.M. at the Registered Office of the Company.The agenda for the meeting includes the consideration and approval of several critical items. Key among these matters are the Consolidated and Standalone Unaudited Financial Results for the quarter ended June 30, 2026. Additionally, the directors will review and approve the Directors Report, Corporate Governance Report, and Secretarial Auditors' Report covering the financial year 2025-2026.
The Board is also tasked with fixing the date, time, and agenda for the forthcoming 82nd Annual General Meeting of the Company, which will be conducted through a physical mode, along with approving the relevant Notice. Any other business will be taken up with the permission of the Chair.
In a market operations update, TCM Limited reiterated the status of its trading window. This announcement follows an earlier intimation issued on June 26, 2026, confirming that the trading window for the company will re-open exactly 48 hours after the declaration of the financial results.
TCM Limited operates manufacturing facilities at Mettur Dam and Kalady.
Stock Price Movement
At 10:33, TCM Ltd shares are currently steady in the market trading at ₹45.00, holding firm on zero percent change. Throughout the session, the stock moved between an intraday low of ₹45.00 and a high of ₹46.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.